300878 维康药业
已收盘 09-30 15:00:00
资讯
新帖
简况
维康药业(300878.SZ):黄甲软肝颗粒获批开展用于慢性乙型病毒性肝炎肝纤维化的III期临床试验
智通财经 · 09-15
维康药业(300878.SZ):黄甲软肝颗粒获批开展用于慢性乙型病毒性肝炎肝纤维化的III期临床试验
维康药业连亏3年半 2020年上市募8.3亿国联民生保荐
中金财经 · 09-11
维康药业连亏3年半 2020年上市募8.3亿国联民生保荐
维康药业(300878)披露药品生产许可证变更公告,9月10日股价下跌5.1%
证券之星 · 09-10
维康药业(300878)披露药品生产许可证变更公告,9月10日股价下跌5.1%
维康药业(300878)披露2026年半年度报告,8月31日股价上涨2.12%
证券之星 · 08-31
维康药业(300878)披露2026年半年度报告,8月31日股价上涨2.12%
维康药业(300878)2026年中报简析:营收上升亏损收窄,盈利能力上升
证券之星 · 08-30
维康药业(300878)2026年中报简析:营收上升亏损收窄,盈利能力上升
维康药业(300878)6月30日股东户数0.81万户,较上期增加8.79%
证券之星 · 08-29
维康药业(300878)6月30日股东户数0.81万户,较上期增加8.79%
维康药业(300878)披露获得药品补充申请批准通知书,8月10日股价下跌4.51%
证券之星 · 08-10
维康药业(300878)披露获得药品补充申请批准通知书,8月10日股价下跌4.51%
维康药业最新公告:金钱草胶囊获药品补充申请批准
证券之星 · 08-10
维康药业最新公告:金钱草胶囊获药品补充申请批准
维康药业(300878)披露部分募集资金专户注销公告,7月22日股价下跌0.48%
证券之星 · 07-22
维康药业(300878)披露部分募集资金专户注销公告,7月22日股价下跌0.48%
维康药业(300878)披露更换持续督导保荐代表人公告,7月15日股价上涨1.95%
证券之星 · 07-15
维康药业(300878)披露更换持续督导保荐代表人公告,7月15日股价上涨1.95%
维康药业:公司黄甲软肝颗粒项目处于Ⅲ期临床研究阶段
证券之星 · 07-09
维康药业:公司黄甲软肝颗粒项目处于Ⅲ期临床研究阶段
维康药业获得发明专利授权:“一种参丹通脑滴丸的药物组合物及制备方法”
证券之星 · 07-04
维康药业获得发明专利授权:“一种参丹通脑滴丸的药物组合物及制备方法”
维康药业最新公告:产品感冒清热颗粒中选全国中成药采购联盟集采
证券之星 · 06-22
维康药业最新公告:产品感冒清热颗粒中选全国中成药采购联盟集采
维康药业(300878)披露控股股东部分股份质押公告,6月1日股价下跌3.51%
证券之星 · 06-01
维康药业(300878)披露控股股东部分股份质押公告,6月1日股价下跌3.51%
维康药业(300878)披露2025年度股东会决议公告,5月20日股价上涨2.22%
证券之星 · 05-20
维康药业(300878)披露2025年度股东会决议公告,5月20日股价上涨2.22%
股市必读:维康药业5月15日涨停收盘,收盘价36.2元
证券之星 · 05-18
股市必读:维康药业5月15日涨停收盘,收盘价36.2元
5月15日维康药业(300878)龙虎榜数据:机构净卖出1821.63万元
证券之星 · 05-15
5月15日维康药业(300878)龙虎榜数据:机构净卖出1821.63万元
异动快报:维康药业(300878)5月15日14点8分触及涨停板
证券之星 · 05-15
异动快报:维康药业(300878)5月15日14点8分触及涨停板
维康药业(300878)股东刘忠良质押420万股,占总股本2.9%
证券之星 · 05-11
维康药业(300878)股东刘忠良质押420万股,占总股本2.9%
每周股票复盘:维康药业(300878)2025年亏损拟不分配利润
证券之星 · 05-03
每周股票复盘:维康药业(300878)2025年亏损拟不分配利润
加载更多
公司概况
公司名称:
浙江维康药业股份有限公司
所属行业:
医药制造业
上市日期:
2020-08-24
主营业务:
浙江维康药业股份有限公司的主营业务是现代中药及西药的研发、生产和销售。公司的主要产品是银黄滴丸、益母草软胶囊、益母草分散片、七叶神安分散片、枫蓼肠胃康分散片、人参健脾片等中成药、罗红霉素软胶囊、灵芝孢子粉(破壁)。公司“经产良药益母草的多维评价与开发应用”荣获四川省科学技术进步奖一等奖;“浙西南特色中药材产业提升关键技术研究与示范”荣获浙江省科学技术进步奖三等奖;“银黄滴丸的二次开发研究”荣获浙江省药学会科学技术奖二等奖。截至报告期末,公司1个药品获得了浙江省高新技术产品证书,5个药品被浙江省经信委评为省级工业新产品,8个药品被登记为浙江省科学技术成果。
发行价格:
41.34
{"stockData":{"symbol":"300878","market":"SZ","secType":"STK","nameCN":"维康药业","latestPrice":30.16,"timestamp":1790751822000,"preClose":29.98,"halted":0,"volume":1202700,"delay":0,"changeRate":0.006,"floatShares":144000000,"shares":145000000,"eps":-1.2804,"marketStatus":"已收盘","change":0.18,"latestTime":"09-30 15:00:00","open":30.17,"high":30.57,"low":29.3,"amount":36359600,"amplitude":0.0424,"askPrice":30.16,"askSize":40,"bidPrice":30.15,"bidSize":6,"shortable":0,"etf":0,"ttmEps":-1.2804,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":29.98,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":32.98,"lowLimit":26.98,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":144790322,"isCdr":false,"pbRate":4.89,"roa":"--","roe":"--","epsLYR":-1.57,"committee":0.082353,"marketValue":4367000000,"turnoverRate":0.0083,"status":0,"floatMarketCap":4347000000},"requestUrl":"/m/hq/s/300878","defaultTab":"news","newsList":[{"id":"2667832610","title":"维康药业(300878.SZ):黄甲软肝颗粒获批开展用于慢性乙型病毒性肝炎肝纤维化的III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832610","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667832610?lang=zh_cn&edition=full","pubTime":"2026-09-15 16:15","pubTimestamp":1789460131,"startTime":"0","endTime":"0","summary":"智通财经APP讯,维康药业(300878.SZ)发布公告,公司于近日收到国家药品监督管理局核准签发的黄甲软肝颗粒的《药物临床试验补充申请批准通知书》,经审查,黄甲软肝颗粒临床试验申请符合药品注册的有关要求,在进一步完善临床试验方案的基础上,同意开展用于慢性乙型病毒性肝炎肝纤维化的III期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBJ","MDTX","BMED","300878","PSYK","IBBQ","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666254772","title":"维康药业连亏3年半 2020年上市募8.3亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2666254772","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666254772?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:46","pubTimestamp":1789116364,"startTime":"0","endTime":"0","summary":"中国经济网北京9月11日讯 维康药业 日前披露2026年半年度报告。今年上半年,公司实现营业收入1.26亿元,同比增长10.11%;归属于上市公司股东的净利润为-2225.56万元;归属于上市公司股东的扣除非经常性损益的净利润为-2012.06万元;经营活动产生的现金流量净额为-2462.41万元。 维康药业于上市次日即2020年8月25日创下截至目前的股价最高点109.80元。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/11/20260911608573.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/11/20260911608573.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260911/32367445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["601456","BK1564","BK0276","IPOS","300878","01456","BK0239","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666956262","title":"维康药业(300878)披露药品生产许可证变更公告,9月10日股价下跌5.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666956262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666956262?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:11","pubTimestamp":1789035093,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,维康药业报收于33.15元,较前一交易日下跌5.1%,最新总市值为48亿元。该股当日开盘35.28元,最高35.36元,最低32.67元,成交额达1.04亿元,换手率为2.15%。公司于近日取得浙江省药品监督管理局换发的《药品生产许可证》,生产负责人由丁京伟变更为孟召光。本次变更系基于公司日常经营管理需要,已依法完成相关手续。本次变更不会对公司正常生产经营及经营业绩产生重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000034565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663072511","title":"维康药业(300878)披露2026年半年度报告,8月31日股价上涨2.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663072511","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663072511?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:34","pubTimestamp":1788172445,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,维康药业报收于32.68元,较前一交易日上涨2.12%,最新总市值为47.32亿元。该股当日开盘31.2元,最高33.3元,最低31.01元,成交额达1.37亿元,换手率为2.94%。近日,维康药业披露《2026年半年度报告》。报告显示,公司2026年上半年营业收入为126,158,518.77元,较上年同期增长10.11%;归属于上市公司股东的净利润为-22,255,603.93元,同比亏损收窄65.34%;扣除非经常性损益后的净利润为-20,120,582.37元,同比改善68.96%。经营活动产生的现金流量净额为-24,624,078.54元,同比下降155.45%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100029122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663774048","title":"维康药业(300878)2026年中报简析:营收上升亏损收窄,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663774048","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663774048?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:31","pubTimestamp":1788042706,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期维康药业发布2026年中报。截至本报告期末,公司营业总收入1.26亿元,同比上升10.11%,归母净利润-2225.56万元,同比上升65.34%。本报告期维康药业盈利能力上升,毛利率同比增幅84.79%,净利率同比增幅68.64%。),公司上市来已有年报6份,亏损年份3次,显示生意模式比较脆弱。财报体检工具显示:建议关注公司现金流状况建议关注公司应收账款状况本文数据来源于维康药业2026年中报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012486","title":"维康药业(300878)6月30日股东户数0.81万户,较上期增加8.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012486","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012486?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:19","pubTimestamp":1787995162,"startTime":"0","endTime":"0","summary":"证券之星消息,近日维康药业披露,截至2026年6月30日公司股东户数为8106.0户,较3月31日增加655.0户,增幅为8.79%。在中药行业个股中,维康药业股东户数低于行业平均水平,截至6月30日,中药行业平均股东户数为5.16万户。从股价来看,2026年3月31日至2026年6月30日,维康药业区间涨幅为17.56%,在此期间股东户数增加655.0户,增幅为8.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658932976","title":"维康药业(300878)披露获得药品补充申请批准通知书,8月10日股价下跌4.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658932976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658932976?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:23","pubTimestamp":1786371797,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘,维康药业报收于33.27元,较前一交易日下跌4.51%,最新总市值为48.17亿元。公司于近日披露《关于获得药品补充申请批准通知书的公告》。公告显示,浙江维康药业股份有限公司收到国家药品监督管理局核准签发的药品补充申请批准通知书,批准金钱草胶囊变更药品说明书中安全性等内容,以及变更制剂处方中的辅料。注册标准执行国家药品标准及此前的补充申请要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000034225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658934537","title":"维康药业最新公告:金钱草胶囊获药品补充申请批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2658934537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658934537?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:43","pubTimestamp":1786369402,"startTime":"0","endTime":"0","summary":"维康药业(300878.SZ)公告称,公司近日收到国家药品监督管理局核准签发的金钱草胶囊药品补充申请批准通知书,批准变更药品说明书中安全性内容及制剂处方中的辅料,并同意新增浙江维康瓯江胶囊有限公司的明胶空心胶囊在该品中使用。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000032938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653766692","title":"维康药业(300878)披露部分募集资金专户注销公告,7月22日股价下跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653766692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653766692?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:32","pubTimestamp":1784730739,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘,维康药业报收于27.17元,较前一交易日下跌0.48%,最新总市值为39.34亿元。该股当日开盘27.28元,最高28.87元,最低26.87元,成交额达1.21亿元,换手率为3.02%。公司于近日披露《关于部分募集资金专户注销的公告》。公告显示,浙江维康药业股份有限公司因使用部分超募资金永久补充流动资金,已于2026年7月22日完成对中国农业银行股份有限公司丽水莲都支行募集资金专户的注销,账户余额已转至公司基本账户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651445958","title":"维康药业(300878)披露更换持续督导保荐代表人公告,7月15日股价上涨1.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651445958","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651445958?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:31","pubTimestamp":1784107918,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘,维康药业报收于34.45元,较前一交易日上涨1.95%,最新总市值为49.88亿元。维康药业近日披露《关于更换持续督导保荐代表人的公告》。公告显示,公司于近日收到国联民生证券承销保荐有限公司出具的函件,原持续督导保荐代表人钟德颂先生因工作调整不再担任公司持续督导保荐代表人,由孙闽先生接替其职务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500033806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650458924","title":"维康药业:公司黄甲软肝颗粒项目处于Ⅲ期临床研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2650458924","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650458924?lang=zh_cn&edition=full","pubTime":"2026-07-09 20:48","pubTimestamp":1783601294,"startTime":"0","endTime":"0","summary":"证券之星消息,维康药业(300878)07月08日在投资者关系平台上答复投资者关心的问题。投资者提问:请问董秘,公司黄甲软肝颗粒3期临床试验需要多久,目前患者入组情况如何?维康药业回复:尊敬的投资者,您好!公司黄甲软肝颗粒项目处于Ⅲ期临床研究阶段,后续公司会在定期报告中详细说明主要研发项目及其研发进展情况,另外如有相关需披露事项公司会按照规定及时披露,敬请持续关注公司公告。感谢您对公司的关注,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900040331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648498660","title":"维康药业获得发明专利授权:“一种参丹通脑滴丸的药物组合物及制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2648498660","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648498660?lang=zh_cn&edition=full","pubTime":"2026-07-04 03:45","pubTimestamp":1783107933,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示维康药业新获得一项发明专利授权,专利名为“一种参丹通脑滴丸的药物组合物及制备方法”,专利申请号为CN202511289382.9,授权日为2026年7月3日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070400003653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645026217","title":"维康药业最新公告:产品感冒清热颗粒中选全国中成药采购联盟集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2645026217","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645026217?lang=zh_cn&edition=full","pubTime":"2026-06-22 18:40","pubTimestamp":1782124803,"startTime":"0","endTime":"0","summary":"维康药业(300878.SZ)公告称,公司产品感冒清热颗粒中选全国中成药采购联盟集中带量采购。该产品2025年度销售收入为898.72万元,占公司2025年度营收的3.99%;2026年第一季度销售收入为131.20万元,占公司2026年第一季度营收的1.88%。本次中选将有利于扩大产品销售规模,提高市场占有率,对公司未来经营业绩具有积极影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200028877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640930221","title":"维康药业(300878)披露控股股东部分股份质押公告,6月1日股价下跌3.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640930221","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640930221?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:50","pubTimestamp":1780307424,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,维康药业报收于30.8元,较前一交易日下跌3.51%,最新总市值为44.6亿元。该股当日开盘31.98元,最高32.59元,最低29.89元,成交额达1.37亿元,换手率为3.09%。近日,维康药业发布《关于控股股东、实际控制人部分股份质押的公告》。质押股份不存在限售、冻结情形,亦无补充质押。截至公告日,刘忠良累计质押股份53,200,000股,占其所持股份60.34%,占公司总股本36.74%。相关股份不存在平仓风险,不影响公司控制权稳定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100027577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636848666","title":"维康药业(300878)披露2025年度股东会决议公告,5月20日股价上涨2.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636848666","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636848666?lang=zh_cn&edition=full","pubTime":"2026-05-20 17:43","pubTimestamp":1779270192,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,维康药业报收于34.6元,较前一交易日上涨2.22%,最新总市值为50.1亿元。该股当日开盘33.97元,最高35.21元,最低33.52元,成交额达2.17亿元,换手率为4.37%。维康药业于近日披露《2025年度股东会决议公告》。出席会议股东共27人,代表股份占公司有表决权股份总数的73.6198%。其中,关于董事2025年度薪酬及2026年度薪酬方案的议案涉及关联股东回避表决。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000034315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636013663","title":"股市必读:维康药业5月15日涨停收盘,收盘价36.2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2636013663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636013663?lang=zh_cn&edition=full","pubTime":"2026-05-18 01:39","pubTimestamp":1779039550,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,维康药业报收于36.2元,上涨19.99%,涨停,换手率8.56%,成交量12.34万手,成交额4.22亿元。当日关注点来自交易信息汇总:维康药业5月15日涨停收盘,收盘价36.2元,盘中多次开板,最终封单资金为483.63万元。来自龙虎榜上榜:维康药业因日涨幅达到15%的前5只证券之一,于5月15日登龙虎榜,近5个交易日内首次上榜。交易信息汇总维康药业5月15日涨停收盘,收盘价36.2元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800000699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635707472","title":"5月15日维康药业(300878)龙虎榜数据:机构净卖出1821.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635707472","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635707472?lang=zh_cn&edition=full","pubTime":"2026-05-15 17:26","pubTimestamp":1778837190,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年5月15日公布的交易公开信息显示,维康药业因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年5月15日收盘,维康药业报收于36.2元,上涨19.99%,涨停,换手率8.56%,成交量12.34万手,成交额4.22亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出1821.63万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500031520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635770175","title":"异动快报:维康药业(300878)5月15日14点8分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2635770175","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635770175?lang=zh_cn&edition=full","pubTime":"2026-05-15 14:10","pubTimestamp":1778825459,"startTime":"0","endTime":"0","summary":"证券之星5月15日盘中消息,14点8分维康药业(300878)触及涨停板。其所属行业中药目前下跌。领涨股为维康药业。该股为肝炎概念,保健品,流感概念热股。5月14日的资金流向数据方面,主力资金净流入257.84万元,占总成交额2.73%,游资资金净流入285.83万元,占总成交额3.02%,散户资金净流出543.68万元,占总成交额5.75%。近5日资金流向一览见下表:维康药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500021404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634740079","title":"维康药业(300878)股东刘忠良质押420万股,占总股本2.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634740079","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634740079?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:31","pubTimestamp":1778495509,"startTime":"0","endTime":"0","summary":"证券之星消息,维康药业5月11日公开信息显示,股东刘忠良向王敏合计质押420.0万股,占总股本2.9%。质押详情见下表:截止本公告日,股东刘忠良已累计质押股份3520.0万股,占其持股总数的39.93%,股东刘忠姣已累计质押股份600.0万股,占其持股总数的60.78%。维康药业主营业务:现代中药及西药的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100028779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300878","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632670979","title":"每周股票复盘:维康药业(300878)2025年亏损拟不分配利润","url":"https://stock-news.laohu8.com/highlight/detail?id=2632670979","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632670979?lang=zh_cn&edition=full","pubTime":"2026-05-03 06:56","pubTimestamp":1777762571,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,维康药业报收于28.58元,较上周的25.85元上涨10.56%。本周,维康药业4月30日盘中最高价报29.17元。股本股东变化股东户数变动截至2026年3月31日,维康药业股东户数为7451.0户,较2025年12月31日增加167.0户,增幅2.29%。会议决定2025年度不进行利润分配,不送红股,不以资本公积金转增股本。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300878"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790914745238,"stockEarnings":[{"period":"1week","weight":-0.0318},{"period":"1month","weight":-0.0771},{"period":"3month","weight":-0.154},{"period":"6month","weight":0.1166},{"period":"1year","weight":0.331},{"period":"ytd","weight":0.1823}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江维康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8106人(较上一季度增加8.79%)","perCapita":"17779股","listingDate":"2020-08-24","address":"浙江省丽水市莲都区经济开发区遂松路2号","registeredCapital":"14479万元","survey":" 浙江维康药业股份有限公司的主营业务是现代中药及西药的研发、生产和销售。公司的主要产品是银黄滴丸、益母草软胶囊、益母草分散片、七叶神安分散片、枫蓼肠胃康分散片、人参健脾片等中成药、罗红霉素软胶囊、灵芝孢子粉(破壁)。公司“经产良药益母草的多维评价与开发应用”荣获四川省科学技术进步奖一等奖;“浙西南特色中药材产业提升关键技术研究与示范”荣获浙江省科学技术进步奖三等奖;“银黄滴丸的二次开发研究”荣获浙江省药学会科学技术奖二等奖。截至报告期末,公司1个药品获得了浙江省高新技术产品证书,5个药品被浙江省经信委评为省级工业新产品,8个药品被登记为浙江省科学技术成果。","listedPrice":41.34},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维康药业(300878)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维康药业(300878)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维康药业,300878,维康药业股票,维康药业股票老虎,维康药业股票老虎国际,维康药业行情,维康药业股票行情,维康药业股价,维康药业股市,维康药业股票价格,维康药业股票交易,维康药业股票购买,维康药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维康药业(300878)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维康药业(300878)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}